Directory
>
Michael Metzger
Michael Metzger
Member Board of Directors | Pyxis Oncology
New York, New York, United States
Michael Metzger
Summary
Michael Metzger is a seasoned executive in the biotechnology sector, currently serving as the CEO of Syndax Pharmaceuticals, where he is instrumental in developing targeted cancer therapies. With a robust background that spans from managing startups to steering companies through IPOs, he has a proven ability to enhance company value through strategic financial maneuvers and team development. His leadership experience includes significant roles on boards of various biopharmaceutical firms, reflecting his deep commitment to the life sciences industry. Michael's expertise encompasses a range of areas, including business development, mergers and acquisitions, and venture capital. He holds an MBA in Finance from NYU Stern and a BA in Political Science from The George Washington University, equipping him with a strong analytical foundation. His career trajectory demonstrates a consistent focus on innovation and transformative therapies, highlighting his dedication to advancing healthcare solutions. Beyond his professional pursuits, Michael is known for his strategic thinking and ability to adapt to the evolving landscape of biotechnology.
Michael Metzger
Work Experience
Member Board of Directors at
Pyxis Oncology
June 2024 - Present
Chief Executive Officer and Director at
Syndax Pharmaceuticals
February 2022 - Present
Member Board of Directors at
CTI BioPharma
January 2017 - July 2023
Member Board of Directors at
Tarveda Therapeutics
June 2017 - April 2022
President, Chief Operating Officer and Director at
Syndax Pharmaceuticals
May 2015 - January 2022
President and Chief Operating Officer at
Regado BioSciences, Inc.
December 2013 - April 2015
President and Chief Executive Officer at
Regado BioSciences, Inc.
October 2014 - April 2015
Executive Vice President and Chief Operating Officer at
Mersana Therapeutics
March 2011 - November 2013
Member Board of Directors at
Response Genetics
November 2010 - November 2013
Senior Director Business Development at
Forest Laboratories (now Allergan)
September 2006 - March 2011
VP Corporate Development at
Onconova Therapeutics
September 2001 - September 2006
Managing Director at
Mesa Partners
January 1997 - August 2001
Manager at
Oxford Health Plans
January 1995 - January 1997
Michael Metzger
Education
New York University Stern School of Business, Mba
January 2001 - January 2003
The George Washington University, B.A.
January 1989 - January 1993
Frequently Asked Questions about Michael Metzger
What is Michael Metzger email address?
Michael Metzger's primary email address is ********@syndax.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Michael Metzger work for?
Michael Metzger is a Member Board of Directors at Pyxis Oncology, a company specializing in Pharmaceutical preparations.
Where Michael Metzger graduated from?
Michael Metzger holds a degree in Finance from New York University Stern School of Business.
How can I directly contact Michael Metzger?
To contact Michael Metzger directly, you can use the email address ********@syndax.com. Complete contact information is available upon registration with Muraena.
Who is Michael Metzger?
Michael Metzger is a seasoned executive in the biotechnology sector, currently serving as the CEO of Syndax Pharmaceuticals, where he is instrumental in developing targeted cancer therapies. With a robust background that spans from managing startups to steering companies through IPOs, he has a proven ability to enhance company value through strategic financial maneuvers and team development. His leadership experience includes significant roles on boards of various biopharmaceutical firms, reflecting his deep commitment to the life sciences industry. Michael's expertise encompasses a range of areas, including business development, mergers and acquisitions, and venture capital. He holds an MBA in Finance from NYU Stern and a BA in Political Science from The George Washington University, equipping him with a strong analytical foundation. His career trajectory demonstrates a consistent focus on innovation and transformative therapies, highlighting his dedication to advancing healthcare solutions. Beyond his professional pursuits, Michael is known for his strategic thinking and ability to adapt to the evolving landscape of biotechnology.
Michael`s contact details
********@syndax.com
**@ctibiopharma.com
Colleagues
Vice President, R&D Quality
Vice President of Commercial Development
President & Chief Executive Officer
Chief Commercial Officer
VP, Strategy & Financial Planning
Chief Scientific Officer
SVP Finance and Chief Accounting Officer